Table 1. Invasive Pneumococcal Disease in Children Younger than 5 years after the introduction of the Heptavalent Pneumococcal Conjugate Vaccine in Denmark.
PCV7 serotypes | Non-Vaccinated | PCV7-vaccinated3 | Total | |
Eligible1 | Non-eligible2 | |||
4 | 0 | 0 | 0 | 0 |
6B | 9 | 2 | 0 | 11 |
9V | 2 | 0 | 0 | 2 |
14 | 7 | 2 | 4 | 13 |
18C | 0 | 6 | 1 | 7 |
19F | 1 | 3 | 3 | 7 |
23F | 0 | 3 | 2 | 5 |
all | 19 (42%) | 16 (36%) | 10 (22%) | 45 (100%) |
Additional serotypes in PCV13 | ||||
1 | 1 | 12 | 12 | 25 |
3 | 2 | 1 | 2 | 5 |
5 | 0 | 0 | 1 | 1 |
6A | 3 | 2 | 5 | 10 |
7F | 2 | 15 | 29 | 46 |
19A | 2 | 2 | 14 | 18 |
all | 10 (10%) | 32 (30%) | 63 (60%) | 105 (100%) |
Other serotypes 4 | 16 (42%) | 0 | 22 (58%) | 38 (100%) |
PCR | 2 (67%) | 1 (33%) | 0 | 3 (100%) |
Total | 47 | 49 | 95 | 191 |
Eligible: child within the age group targeted for primary PCV7/PCV13 vaccination or catch-up program who presented an IPD episode before vaccination.
Not-eligible: child outside the age group targeted for primary PCV7/PCV13 vaccination or catch-up program with PCV7.
PCV7-vaccinated: children who presented an IPD episode after PCV7 immunization, regardless of the number of doses received, the time of onset of illness after vaccination and the age of immunization.
Other serotypes: 6C, 8, 10B, 12F, 15B/C, 16F, 18F, 22F, 23F, 24F, 33F, 35B, 35F. No clear predominance of any serotype was observed. None of the patients presenting IPD due to PCV7 or PCV13 serotypes were vaccinated with PCV13.